Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michele Basile
Activity-Based Costing and Budget Analysis of Vedolizumab Versus Conventional Treatments in Ulcerative Colitis and Crohn’s Disease
Global and Regional Health Technology Assessment
Health Policy
Related publications
Cost-Minimization Analysis of Infliximab Versus Adalimumab in the Treatment of Crohn’s Disease and Ulcerative Colitis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Autoimmune Thyroid Diseases Concomitant With Crohn’s Disease and Ulcerative Colitis
Journal of Thyroid Disorders & Therapy
Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn’s Disease and Ulcerative Colitis
Journal of Immunology Research
Medicine
Allergy
Immunology
Vedolizumab in Ulcerative Colitis; A Budget Impact Model for a Novel Drug in a Recession Environment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Correlation of Biomarker Expression in Colonic Mucosa With Disease Phenotype in Crohn’s Disease and Ulcerative Colitis
Digestive Diseases and Sciences
Physiology
Gastroenterology
Crohn’s Disease and Ulcerative Colitis Are Associated With Elevated Standardized Mortality Ratios
Inflammatory Bowel Diseases
Allergy
Immunology
Gastroenterology
Current and Novel Treatments for Ulcerative Colitis
Fecal Calprotectin and Clinical Disease Activity in Pediatric Ulcerative Colitis
ISRN Gastroenterology
A Maximum Likelihood Estimator of a Markov Model for Disease Activity in Crohn’s Disease and Ulcerative Colitis for Annually Aggregated Partial Observations
Medical Decision Making
Health Policy
